Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1658 | 2021 |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... Nature 592 (7855), 616-622, 2021 | 1455 | 2021 |
Vaccine breakthrough infections with SARS-CoV-2 variants E Hacisuleyman, C Hale, Y Saito, NE Blachere, M Bergh, EG Conlon, ... New England Journal of Medicine 384 (23), 2212-2218, 2021 | 741 | 2021 |
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ... Nature 595 (7867), 426-431, 2021 | 723 | 2021 |
Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico DF Robbiani, L Bozzacco, JR Keeffe, R Khouri, PC Olsen, A Gazumyan, ... Cell 169 (4), 597-609. e11, 2017 | 344 | 2017 |
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination A Cho, F Muecksch, D Schaefer-Babajew, Z Wang, S Finkin, C Gaebler, ... Nature 600 (7889), 517-522, 2021 | 262 | 2021 |
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... Immunity 54 (8), 1853-1868. e7, 2021 | 242 | 2021 |
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape F Schmidt, Y Weisblum, M Rutkowska, D Poston, J DaSilva, F Zhang, ... Nature 600 (7889), 512-516, 2021 | 208 | 2021 |
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost F Muecksch, Z Wang, A Cho, C Gaebler, T Ben Tanfous, J DaSilva, ... Nature 607 (7917), 128-134, 2022 | 199 | 2022 |
Persistent cellular immunity to SARS-CoV-2 infection G Breton, P Mendoza, T Hägglöf, TY Oliveira, D Schaefer-Babajew, ... Journal of Experimental Medicine 218 (4), e20202515, 2021 | 139 | 2021 |
A combination of two human monoclonal antibodies prevents Zika virus escape mutations in non-human primates JR Keeffe, KKA Van Rompay, PC Olsen, Q Wang, A Gazumyan, ... Cell reports 25 (6), 1385-1394. e7, 2018 | 70 | 2018 |
Risk of Zika microcephaly correlates with features of maternal antibodies DF Robbiani, PC Olsen, F Costa, Q Wang, TY Oliveira, N Nery, ... Journal of Experimental Medicine 216 (10), 2302-2315, 2019 | 55 | 2019 |
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination D Schaefer-Babajew, Z Wang, F Muecksch, A Cho, M Loewe, M Cipolla, ... Nature 613 (7945), 735-742, 2023 | 48 | 2023 |
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... BioRxiv, 2021 | 43 | 2021 |
Increased potency and breadth of SARS-CoV-2 neutralizing antibodies after a third mRNA vaccine dose F Muecksch, Z Wang, A Cho, C Gaebler, TB Tanfous, J DaSilva, ... BioRxiv, 2022.02. 14.480394, 2022 | 38 | 2022 |
Antibody evolution to SARS-CoV-2 after single-dose Ad26. COV2. S vaccine in humans A Cho, F Muecksch, Z Wang, T Ben Tanfous, J DaSilva, R Raspe, ... Journal of Experimental Medicine 219 (8), e20220732, 2022 | 13 | 2022 |
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination D Schaefer-Babajew, Z Wang, F Muecksch, A Cho, R Raspe, B Johnson, ... medRxiv, 2022 | 12 | 2022 |
High genetic barrier to escape from human polyclonal SARS-CoV-2 neutralizing antibodies F Schmidt, Y Weisblum, M Rutkowska, D Poston, JD Silva, F Zhang, ... bioRxiv, 2021.08. 06.455491, 2021 | 9 | 2021 |
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants M Agudelo, F Muecksch, D Schaefer-Babajew, A Cho, J DaSilva, ... Journal of Experimental Medicine 219 (9), e20220367, 2022 | 7 | 2022 |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 10 Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... | 4* | 2021 |